Remdesivir, nirmatrelvir-ritonavir, baricitinib can be used to treat COVID-19 in pediatric patients
April 1, 2022 -- Antivirals are one of the limited options for treatment of COVID-19 in the pediatric population.
COVID town hall panelists offer advice on supporting children’s mental health
March 21, 2022 -- Panelists discussed learning loss that continued during the omicron surge and the importance of regular school attendance.
Vaccine for children under 5 delayed so FDA can review data on 3rd dose
Feb. 11, 2022 -- The Food and Drug Administration postponed a Feb. 15 meeting of its Vaccines and Related Biological Products Advisory Committee to discuss the Pfizer-BioNTech COVID-19 vaccine for children ages 6 months to 5 years and said the meeting likely will occur later this spring.
Pfizer requests FDA authorization of COVID vaccine for children under 5
Feb. 2, 2022 -- A COVID-19 vaccine for children under 5 years could be available later this month, but it must undergo a rigorous review from two federal agencies.
Past, present, future of omicron discussed at AAP town hall
Jan. 10, 2022 - Testing for SARS-CoV-2, quarantine guidelines and keeping kids safe in school were among the topics addressed by AAP experts.
FDA grants EUA for COVID vaccine in 5- to 11-year-olds; AAP experts answer questions ahead of roll-out
Oct. 29, 2021 – Participants in an AAP town hall discussed how pediatricians can prepare to administer the vaccine and instill confidence in parents.
FDA panel: Benefits of COVID-19 vaccine for ages 5-11 outweigh risks
Oct. 26, 2021 – Committee members said they want to protect children from COVID-related infections, hospitalizations and deaths as well as disruptions to their education.
Pediatricians reflect on how pandemic played out over past year
Feb. 17, 2021 -- AAP News caught up with pediatricians across the country who shared stories early in the pandemic of how they were innovating, adapting and digging deep to care for their patients, communities and colleagues.
Pediatricians, practice administrators share lessons learned during pandemic
Feb. 17, 2021 -- AAP News reached out to pediatricians and practice administrators on social media and asked what lesson they learned during the pandemic — professional, personal, serious or tongue-in-cheek. Here’s what they told us.
CDC, Department of Education issue guidance for schools to reopen, stay open
Feb. 12, 2021 -- Guidance and a science brief from the Centers for Disease Control and Prevention (CDC) and a handbook from the U.S. Department of Education aim to help schools determine when to reopen during the COVID-19 pandemic.
COVID-19 pandemic timeline
Feb. 11, 2021 -- It has been just over a year since COVID-19 was discovered. This timeline shows the major milestones of the pandemic.
Report examines medical procedure, cloth mask combinations to block SARS-CoV-2
Feb. 10, 2021 -- Ensuring that masks fit tightly can improve how well they reduce exposure to and transmission of the virus.
AAP recommends COVID-19 vaccines for eligible teens
Feb. 2, 2021 -- The AAP recommends everyone 16 year and older who meet the criteria for a priority group get vaccinated against COVID-19.
COVID-19 fuels questions about patient waivers, standard of care for telemedicine
Sept. 16, 2020 -- The AAP Committee on Medical Liability and Risk Management is answering some common liability questions related to COVID-19.
New CPT code covers prep time, supplies, PPE needed during pandemic
Sept. 16, 2020 -- Code 99072 is to be reported only once per in-person patient encounter per provider identification number, regardless of the number of services rendered at that encounter.
Surveillance, research needed to identify optimal treatments for MIS-C
Sept. 16, 2020 -- Some experts hypothesize that multisystem inflammatory syndrome in children (MIS-C) results from immune-mediated injury triggered by SARS-CoV-2 infection. Therefore, once COVID-19 vaccines become available for children, it will be crucial to evaluate MIS-C as a possible COVID-19 vaccine safety outcome.
Ask the Expert: Are anti-viral drugs available to treat COVID-19 infections?
Aug. 19, 2020 -- H. Cody Meissner, M.D., FAAP, discusses whether remdesivir, hydroxychloroquine, HIV protease inhibitors and convalescent plasma can be used to treat COVID-19 infections.
AAP: HHS action on pharmacy vaccination ‘misguided’
Aug. 19, 2020 -- Federal officials invoked public health emergency authority to preempt state law on pharmacist administration of vaccines to children.
FDA partners with global agencies on development of COVID-19 therapeutics for children
July 28, 2020 -- Worldwide partnerships help ensure that children’s therapeutic needs are addressed without exposing pediatric patients to unnecessary or duplicative clinical trials.
New York chapters help pediatricians confront challenges posed by pandemic
July 28, 2020 -- Chapters provided clinical guidance and support to members, and consulted with state agencies on school closings and multisystem inflammatory syndrome in children.
Steep declines seen in ED visits by children during COVID-19 pandemic
July 28, 2020 -- Visits were down 72% among children ages 10 and younger and 71% among those ages 11-14 compared to 2019, likely due in part to fear of contracting COVID-19.
AAP provides guidance on diagnosing, treating MIS-C
July 13, 2020 -- Multisystem Inflammatory Syndrome in Children is a rare but serious condition linked to COVID-19. The AAP recommends a multidisciplinary approach to caring for these patients.
AAP: Limit visitors to hospitalized children during COVID-19 pandemic
July 1, 2020 -- The interim AAP guidance also addresses the importance of providing support to hospitalized children and families, even if it must be done virtually.
June 25, 2020 -- The CDC’s vaccine committee has formed a work group to study COVID-19 vaccines as they are developed and formulate policies for use in the U.S. The group said its objectives are to ensure vaccines are safe, effective and distributed equitably.
June 25, 2020 -- This article for parents describes multisystem inflammatory syndrome in children (MIS-C). MIS-C causes inflammation of many or all of the internal organs, such as the intestines, heart, lungs and kidneys.
Residency programs shift gears to address families’ concerns about COVID-19
June 23, 2020 -- For years, pediatric residency program faculty have partnered with community organizations to teach residents how to address local child health needs and prepare them to be effective child health advocates. When communities began to feel the impact of COVID-19, faculty leaders drew on these partnerships to address families’ pressing concerns.
June 23, 2020 -- The FDA has tested several hand sanitizers manufactured by Eskbiochem SA de CV in Mexico and found methanol, which can cause nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death.
Ask the Expert: Why is vaccine development against COVID-19 disease so difficult?
June 17, 2020 -- H. Cody Meissner, M.D., FAAP, discusses the challenges of conducting clinical trials, defining vaccine effectiveness, ensuring safety and manufacturing and distributing millions of doses.
AAP urges insurers to extend telehealth payments during COVID-19 pandemic
June 3, 2020 -- With expanded coverage and increased payment, telehealth has become a vital way for pediatricians to care for patients, but some carriers plan to stop coverage later this month.
Pediatricians show their mettle as coronavirus sweeps the nation
April 21, 2020 -- Pediatricians around the country have risen to the challenges posed by the coronavirus disease 2019 pandemic.
Brief outlines benefits of using lung ultrasound in children with COVID-19
April 21, 2020 -- Lung ultrasound might be a reasonable method to detect lung abnormalities in children with mild/severe coronavirus disease 2019, according to the research brief.
Case study sheds light on need for more reports on pediatric COVID-19 clinical presentation patterns
April 8, 2020 -- The first case study of an infant with confirmed coronavirus disease 2019 who also was diagnosed and treated for classic Kawasaki disease highlights the growing need to understand the clinical presentation patterns of the disease.